1. HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies
   Catalin Bogdan Satala et al, 2020, Journal of Oncology CrossRef
2. A Reliable and Standardizable Differential PCR and qPCR Methodology Assesses HER2 Gene Amplification in Gastric Cancer
   Ignacio Juarez et al, 2021, Biology CrossRef
3. HER2Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
   Angela N. Bartley et al, 2016, American Journal of Clinical Pathology CrossRef
4. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
   Angela N. Bartley et al, 2016, Archives of Pathology & Laboratory Medicine CrossRef
5. HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery
   Anna Grenda et al, 2020, BMC Gastroenterology CrossRef
6. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
   Angela N. Bartley et al, 2017, Journal of Clinical Oncology CrossRef
7. Could quantitative real-time polymerase chain reaction assay serve as an alternative test method to evaluate human epidermal growth factor receptor 2 status of gastric carcinoma in the South Asian setting?
   D. K. S. Kannangara et al, 2019, Indian Journal of Gastroenterology CrossRef
8. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis
   Xiaoping Li et al, 2016, World Journal of Surgical Oncology CrossRef